vMCO-010

· Nanoscope Therapeutics Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for vMCO-010, covering 2023-11-09 to 2023-11-09. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Effects of a Single Intravitreal Injection of vMCO-010 Optogenetic Therapy in Subjects With Stargardt Disease [Phase 2]

See pricing